16 /100
LOW RISK
Score updated May 29, 2026

HQL — Abrdn Life Sciences Investors Dilution Risk Tracker

Track HQL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HQL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HQL.
🔔 Track HQL — Get forecast alerts →

💹 Market Data

Market Cap$537.31M
Shares Outstanding30.41M
FloatN/A
Cash$75.5K
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 5.2% shares (2025Q4 vs prior)
75 institutional holders · 9.17M shares
#1 Saba Capital Management, L.P. 2.12M shares
#2 MORGAN STANLEY 1.16M shares
#3 Penserra Capital Management LLC 875.1K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest21.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track HQL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HQL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HQL
📊 HQL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HQL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.